Loading...
RCT
ACE Report #9601
Ace Report Cover Arthroplasty

AAOS2017: Assessing major wound complication rate of rivaroxaban, LMWH or placebo in THA


Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

A Prospective Randomized Study Comparing Oral Direct Factor Xa Inhibitor with Lowmolecular- weight Heparin for Evaluation of Surgical Wound Complications Following Total Hip Arthroplasty

Contributing Authors: YS Park YW Moon SJ Lim SM Kim I Yeo C Park RH Gon

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

958 patients scheduled for total hip arthroplasty were randomized to different groups for thromboprophylaxis. In patients <60 years of age (n=600), randomization was to either rivaroxaban, enoxaparin, or placebo. In patients 60 years of age or older (n=358), randomization was to either rivaroxaban or enoxaparin. The purpose of this study was to determine if there were any significant differences b...

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.